Monday, March 23, 2009 2:35:15 PM
I completely agree, disastrous.
But that wasn't the point. My point is that there are so many beaten-down biotechs, real companies with real drugs, that are great value plays. Actually maybe CTIC is a half-dubious example, but it's drug Pixantrone WORKS.
Actually I have some stats skills and was looking at DNDN over the weekend, a candidate for the 20s. But with so much value around, why bet the ranch on it ?
And definitely dont touch IDIX. Do you own MNTA ? Actually it's beaten down, like a call option itself. I own calls.
"....on the biotech battle-field, you need some élan...."
FEATURED ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • Mar 24, 2026 8:30 AM
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
